IOL Chemicals & Pharmaceuticals Downgraded to 'Sell' by MarketsMOJO on Poor Growth and Negative Results.
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has been downgraded to a 'Sell' by MarketsMojo due to its poor long-term growth and negative results. The stock has also underperformed the market in the last year. However, the company has a low Debt to Equity ratio and fair valuation, making it a potential investment opportunity in the future.
IOL Chemicals & Pharmaceuticals, a smallcap company in the chemicals industry, has recently been downgraded to a 'Sell' by MarketsMOJO on August 5th, 2024. This decision was based on the company's poor long-term growth, as its operating profit has only grown at an annual rate of 15.09% over the last 5 years.In addition, the company's results for the quarter ending in March 2024 were negative, with a significant decrease in PBT LESS OI(Q) at Rs 29.68 crore, a -40.7% decrease, and a decrease in PAT(Q) at Rs 27.62 crore, a -35.6% decrease. The company's net sales for the quarter were also at its lowest at Rs 503.92 crore.
Technically, the stock is currently in a Mildly Bearish range, with a deteriorating trend since August 5th, 2024, resulting in a -5.67% return. The key technical factor, MACD, has also been Bearish since the same date.
Despite being a smallcap company, domestic mutual funds hold only 0.17% of the company, which could indicate that they are not comfortable with the company's current price or business. Additionally, the company has underperformed the market in the last year, with a return of only 2.92%, compared to the market's (BSE 500) return of 32.89%.
However, the company does have a low Debt to Equity ratio (avg) at 0.10 times and a fair valuation with a 1.5 Price to Book Value and ROE of 8.3. The stock is currently trading at a discount compared to its average historical valuations. Despite this, the company's profits have fallen by -3.3% in the past year, while the stock has only generated a return of 2.92%.
In conclusion, based on the recent downgrade by MarketsMOJO and the company's poor long-term growth and negative results, it may be wise for investors to consider selling their stock in IOL Chemicals & Pharmaceuticals. However, it is important to note that the company does have a low Debt to Equity ratio and fair valuation, which could potentially make it an attractive investment in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
